Screener
Mirum Pharmaceuticals, Inc. MIRM Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$67.23M-1,047% | -$790.16M-5,284% | -$5.73M+75.9% | $2.91M+120% | -$5.86M+76.2% | ||
| $6.94M+14.5% | $6.87M+13.6% | $6.07M+0.3% | $6.06M+0.1% | $6.06M+3.5% | ||
| $30.57M+65.5% | $36.2M+129% | $19.03M+43.6% | $18.13M+52.2% | $18.47M+56.0% | ||
| -$44.25M-468% | -$228.76M-11,566% | $6.07M— | $39.68M+896% | $12.04M— | ||
| $23K-81.7% | $664K+1,520% | $600K+2,900% | $187K+3.3% | $126K-83.8% | ||
| -$159.99M-2,324% | -$11.57M+28.3% | $0— | -$2.23M+87.7% | -$6.6M+90.9% | ||
| —— | —— | $0— | $0— | $0— | ||
| $211.44M+2,334% | $270.08M+4,147% | $9M+68.5% | $16.1M+317% | $8.69M+19.2% | ||
| $5.82M-64.4% | $28.48M+367% | $15.66M+3,461% | $53.9M+634% | $16.36M+124% | ||
| -$44.28M-472% | -$229.43M-11,360% | $5.47M— | $39.49M+938% | $11.91M— |
FAQ
- How much cash does Mirum Pharmaceuticals, Inc. generate?
- Mirum Pharmaceuticals, Inc. (MIRM) generated -$227.3M in operating cash flow over the trailing twelve months.
- What is Mirum Pharmaceuticals, Inc.'s free cash flow?
- After $1.5M of capital expenditures, Mirum Pharmaceuticals, Inc.'s free cash flow was -$228.7M over the trailing twelve months, down 891.1% year over year.
- Where does Mirum Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Mirum Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
